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Genetic contribution to the development of atten-
tion deficit hyperactivity disorder (ADHD) is well
established. Seven independent genome-wide
linkage scans have been performed to map loci
that increase the risk for ADHD. Although sig-
nificant linkage signals were identified in some of
the studies, there has been limited replications
between the various independent datasets. The
current study gathered the results from all seven
of the ADHD linkage scans and performed a
Genome Scan Meta Analysis (GSMA) to identify
the genomic region with most consistent linkage
evidence across the studies. Genome-wide signifi-
cant linkage (PSR¼0.00034, POR¼0.04) was identi-
fied on chromosome 16 between 64 and 83 Mb. In
addition there are nine other genomic regions
from the GSMA showing nominal or suggestive
evidence of linkage. All these linkage results may
be informative and focus the search for novel
ADHD susceptibility genes.  2008 Wiley-Liss, Inc.
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INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is one of the
most common childhood behavioral disorders characterized by
early onset of age-inappropriate hyperactivity, impulsivity,
and inattentiveness [Asherson, 2004]. Family and twin studies
have consistently shown that genetic factors play an important
role in ADHD etiology with heritability estimated around
76% [Faraone et al., 2005]. Meta analysis of candidate gene
studies has confirmed small but significant association with
variants within or close to genes such as dopamine D4 (DRD4)
and D5 (DRD5) receptor genes [Faraone et al., 2005]. Novel
genes are still to be discovered through hypothesis free
genome-wide linkage and association studies.
To date, seven genome-wide ADHD linkage scans have been
published and some chromosome regions such as 5p13, 14q12,
and 17p11 have been indicated in multiple studies [Fisher
et al., 2002; Bakker et al., 2003; Arcos-Burgos et al., 2004;
Hebebrand et al., 2006; Ogdie et al., 2006; Faraone et al., 2007;
Asherson et al., 2008; Romanos et al., 2008]. However, no
chromosome region has been consistently identified across the
scans and the majority of the findings were unique to each
study. This is not unexpected because the power of individual
scans is likely to be low for a complex trait such as ADHD which
may only have genes of small to moderate effects [Risch and
Merikangas, 1996; Waldman and Gizer, 2006]. A combined
analysis of these studies is expected to provide more power to
detect true linkage signals.
Although pooling the raw genotypic data to perform a new
linkage analysis is an optimal strategy to maximize statistical
power in detecting linkage, there are some difficulties
associated with pooling raw data or interpreting results,
especially when there are phenotypic heterogeneity or genetic
map discrepancies between studies. The genome scan meta
analysis (GSMA) method provides an important alternative
strategy [Wise et al., 1999]. It is a rank-based non-parametric
method specifically developed to evaluate the combined
evidence for linkage from multiple genome scans. Apart from
the power advantage, GSMA is also robust to differences
in study design and analysis method and it is particularly
suitable for identifying linkage regions that show very mild
evidence of linkage across many studies [Levinson et al., 2003;
Lewis et al., 2003]. Here, we apply the GSMA method to all
seven published ADHD genome-wide linkage scans.
MATERIALS AND METHODS
Genome Scan Meta Analysis (GSMA) Method
and Heterogeneity Testing
GSMA divides the genome into N chromosome bins of
approximately equal length (e.g., 120 bins of 30 cM), each bin
containing at least one marker per study. Bin c.n. denotes the
number nth bin on chromosome c from the p terminal (e.g., bin
5.4 is the fourth bin on chromosome 5). For each scan, the most
significant result in each bin is recorded; this could be the
highest LOD score in the interval or the smallest P-value.
Within each study, the bins are ranked according to these
results with the most significant bin ranked N. The ranks
within a bin are then summed across studies to get the summed
rank SR.
Bins with higher SR indicate evidence of linkage across the
studies. The statistic PSR is the probability of observing a
given SR under the null hypothesis of no susceptibility locus in
the bin and it could be derived from a theoretical distribution or
a permutation process. The 5% threshold for a genome-wide
significant linkage is therefore PSR¼ 0.05/N because there
are a total number of N tests within one GSMA analysis
[Wise et al., 1999] and for suggestive evidence of linkage is 1/N.
Another statistic produced by GSMA is POR which is the
probability of observing a given SR for a bin by chance in bins
with the same place in the descending order from random
permuted replicates. Multiple bins with PSR< 0.05 and
POR< 0.05 give empirical evidence of linkage in a GSMA
analysis [Levinson et al., 2003; Lewis et al., 2003].
To account for the sample size difference among studies
which is related to the statistical power to test linkage, the
ranks can be weighted by the number of cases or families
included in each study and the significance of GSMA statistics
evaluated by permutation. By this means, GSMA can explore
the genome to pick up susceptibility loci that do not show
significant linkage signals in a single study but have consistent
sharing across multiple scans.
Compared with the other meta-analysis methods based on
Fisher’s combined P-value strategy, GSMA has the advantage
to be applied on almost all the genome-wide linkage scans for
the following reasons. Firstly, GSMA uses only the relative
significance of a bin (rank) in the respective study. Therefore it
is not necessary to have the same markers genotyped in
different studies as long as there was one marker genotyped in
each bin from each study. Secondly, the different studies do
not need to be analyzed with the same statistical method (e.g.,
the result of parametric LOD score or non-parametric allele
sharing statistics). Most importantly, GSMA can incorporate
both affected sib pair and extended pedigree studies into
the same meta-analysis. These advantages make GSMA
applicable to most available studies and is the most widely
Attention Deficit Hyperactivity Disorder 1393
used method in linkage meta analysis [Levinson et al., 2003;
Lewis et al., 2003]. For a more detailed list of GSMA case
studies, please go to the homepage (http://www.kcl.ac.uk/
depsta/memoge/gsma/).
Heterogeneity among studies can be assessed by the
Q statistic, which is defined as the sum of the squared
deviations of each study’s bin rank from the mean bin
rank within the GSMA framework [Zintzaras and Ioannidis,
2005a]. The significance of Q statistics can be determined by
permutations and it can be adjusted for differing sample
sizes as well. Low between-study heterogeneity indicates
consistency of study results in the same bin. Moreover, since
the Q statistic is associated with the mean rank, an adjusted
statistics Qadjusted can also be computed by permuting only the
bins within 2 average ranks [Zintzaras and Ioannidis,
2005a].
In the current study we used the GSMA program to get
the summed rank SR, PSR, and POR statistics through
10,000 permutations [Pardi et al., 2005]. The 22 autosomes
were divided into 120 bins according to the original GSMA
protocol and the genome-wide significant threshold is 0.05/
120¼ 0.000417, and the threshold for suggestive evidence
of linkage is 0.0083 [Wise et al., 1999; Levinson et al., 2003].
The program HEGESMA was used to get the Qadjusted and its
P-values through 10,000 simulations [Zintzaras and Ioannidis,
2005b]. Both weighted and un-weighted GSMA analysis was
performed. The un-weighted analysis assumes each study has
the same statistical power. To address the power difference
across studies, the weight given to each study in the weighted
analysis was computed as the squared root of the number of
cases in each study as shown in Table I. This weight is not idea
because both affected sib pair and extended pedigree studies
were included in the current analysis and the statistical power
of each study is not strictly proportional to the number of cases.
Therefore un-weighted GSMA analysis results were also
presented.
Application of GSMA to 7 ADHD Scans
All the investigators from the seven published ADHD
linkage scans contributed their original genome scan results
for this GSMA analysis. A summary of the studies is shown in
Table I. While two studies collected extended multi-generation
pedigree samples, the other five adopted the affected sib pair
design. The total number of cases is 2,084 of which 88% are
Caucasian. All the studies applied the DSM-IV diagnostic
criteria in the sample ascertainment process but used different
data capture instruments. In some studies, cases with sub-
threshold diagnosis or comorbid autism were also included in
the analysis. For the current meta-analysis, only linkage
statistics based on the stringent diagnostic criteria were
included. The four studies published earlier were genotyped
on microsatellite panels mapped on the Marshfield genetic
map while the three recent scans were genotyped with SNP
microarrays mapped to the Decode genetic map [Kong et al.,
2002]. For the genetic map positions presented below, all
the original Marshfield map positions were transformed into
Decode map positions. The linkage statistics varied across
studies due to the differences in their original study design and
analysis methods.
RESULTS
The un-weighted and weighted PSR statistics for each of the
120 bins are plotted in Figure 1. Significant thresholds for
nominal (P< 0.05) suggestive (P< 0.0083) and genome-wide
significant (P< 0.00042) linkage are marked. Table II shows
the full details of both weighted and un-weighted GSMA
results, including PSR, POR and the adjusted heterogeneity test
p-values PHet for the 10 bins with at least nominal linkage
signals (P< 0.05) from the un-weighted analysis.
Linkage signals from both the weighted (SR¼ 718,
PSR¼ 0.00038, POR¼ 0.041) and un-weighted (SR¼ 714,
PSR¼ 0.00034, POR¼ 0.04) analyses in bin 16.4 (16q23.1-qter)
were genome-wide significant for PSR (according to Lander and
Kruglyak’s criteria after a Bonferroni correction for the
number of bins) [Lander and Kruglyak, 1995]. The POR of
around 0.04 from both the weighted and un-weighted analyses
enhances the evidence that this bin is linked to ADHD. Nine
additional bins on chromosomes 5, 6, 7, 8, 9, 15, 16, 17 showed
nominal linkage signals (PSR< 0.05) from the un-weighted
analysis. For each of the 10 bins with linkage signals, the PSR
statistics did not differ dramatically between the weighted and
un-weighted analyses with the highest weighted PSR< 0.08
as shown in Table II. Furthermore, no significant rank
heterogeneity among the studies was observed for any of the
10 bins. This heterogeneity test result was expected because
the total number of seven studies provides limited statistical
power to detect heterogeneity when the gene effect is relatively
small or moderate [Lewis and Levinson, 2006].
DISCUSSION
In the current study, our primary un-weighted GSMA
analysis identified a total number of 10 chromosomal regions
with nominal linkage signals (PSR< 0.05). Under the null
hypothesis of no linkage in any of the 120 bins, only 6 such bins
are expected by chance and the probability of observing 10 or
more is 0.077 [Wise et al., 1999]. These results suggest that
some of the bins in our primary GSMA analysis, as nominated
by individual linkage scans collectively, are likely to harbor
ADHD genes.
The most significant finding in this GSMA analysis was
identified in bin 16.4 which covers the chromosome region from
16q23.1 to the q terminal. Details of the linkage statistics
within this bin are plotted in Figure 2. This bin had the
maximum rank (rank¼ 120) in two scans with multipoint
nonparametric LOD¼ 3.1 in the Asherson et al. [2008] study
and MODglobal¼ 3.2 in the Romanos et al. [2008] study.
Nominal linkage signals were also observed in two scans
with Multipoint Nonparametric MLS of 1.05 (rank¼ 109) and
1.08 (rank¼ 105) in the Ogdie et al. [2003] study and the
Bakker et al. [2003] study respectively. Even in the other
three scans with no linkage signal, the ranks for this bin
are also higher than average with ranks of 80, 73 and 112 in
the Faraone et al. [2007] study, the Hebebrand et al. [2006]
study and the Arcos-Burgos et al. [2004] study respectively.
Although none of these scans reached genome-wide signi-
ficance on their own, these moderate findings had collectively
contributed to a genome-wide significant linkage signal as
identified by GSMA.
Interestingly bin 16.3, which is next to bin 16.4 also showed
nominal linkage signal (P¼ 0.017) from the un-weighted
GSMA analysis and suggestive linkage (P¼ 0.0072) in the
weighted GSMA analysis. This observation of clustered
significant linkage bins could be explained by the fact that
one multipoint linkage signal could extend 30–50 cM and
affect the ranks of adjacent bins [Wise et al., 1999]. To explore
this possibility, we repeated the GSMA analysis by shifting
the bin boundaries 15 cM forward [Levinson et al., 2003].
The new bin covering chromosome 16q21–16q24 remained
genome-wide significant and the adjacent bins showed no
linkage signals. These results suggest that one strong linked
locus within the new bin (64–83 Mb on the NCBI genome build
35) may account for both 16.3 and 16.4 signals in our primary
GSMA analysis. It is also supported by the details of the
linkage statistics as shown in Figure 2 that most of the linkage
peaks in bin 16.4 extended to bin 16.3.
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There are more than 200 annotated genes within bin 16.4,
none of which have been previously examined in ADHD
candidate gene association studies due to their lack of
known functional relevance to the disorder. However, a recent
genome-wide association scan found that the CDH13 (a cell
adhesion molecule), which is located on chromosome 16q24, is
associated with methamphetamine dependence [Uhl et al.,
2008]. Another genome-wide QTL association scan using the
IMAGE sample also found markers within CDH13 to be
strongly associated with total ADHD symptom scores within
children diagnosed with ADHD [Jessica Su et al., in this issue].
Whether genetic variations of CDH13 explain the linkage
signals in this region is beyond the scope of the current study.
Further fine mapping studies or combined linkage and
association analysis are expected to address this issue.
Bin 5.3, which covers chromosome 5q11.2–q14.3, is another
region with a nominal linkage signal in our GSMA analysis.
It is worth noting that this bin is 40 cM away from the
chromosome 5p13 region that was indicated as a potential
locus for ADHD by two previous linkage scans [Hebebrand
et al., 2006; Ogdie et al., 2006]. It is unlikely that the GSMA
signal observed in bin 5.3 is contributed by linkage to 5p13 as
the other five studies showed no linkage at this locus. However,
it does not mean we should not pursue the 5p13 linkage
region either, because GSMA only identifies promising regions
and is not used for exclusion mapping. Indeed, further
fine mapping of the 5p13 region has identified genetic variation
of SLC6A3 (dopamine transporter gene) as a potential
explanation for the linkage signal [Ogdie et al., 2004; Friedel
et al., 2007].
TABLE II. Bins With Linkage Signals From the Un-Weighted GSMA
Bin
Boundary Un-weighted Weighted
Genetica
(cM)
Physicalb
(Mb) SR PSR POR PHet SR PSR POR PHet
5.3 71–103 56–88 582 0.04238 0.111 0.76 562 0.07509 0.151 0.86
6.3 65–98 43–91 583 0.04136 0.208 0.77 568 0.06669 0.255 0.83
6.4 98–131 91–132 577 0.04723 0.036 0.76 573 0.06012 0.436 0.64
7.3 60–91 39–78 631 0.01063 0.368 0.45 621 0.01805 0.371 0.27
8.1 0–25 0–13 595 0.03054 0.297 0.80 567 0.06843 0.162 0.85
9.4 81–107 85–106 594 0.03094 0.150 0.40 620 0.01857 0.174 0.40
15.1 0–29 0–31 578 0.04611 0.077 0.32 571 0.06325 0.335 0.31
16.3 65–99 51–78 617 0.01663 0.322 0.47 651 0.00719 0.211 0.55
16.4 99–130 78–88 714 0.00034 0.041 0.60 718 0.00038 0.045 0.40
17.1 0–32 0–11 602 0.02534 0.361 0.69 589 0.04232 0.226 0.55
aGenetic map positions are according to Decode genetic map.
bPhysical map positions are according to NCBI Genome Build 35.
Fig. 1. Weighted (red) and unweighted (blue) log10(PSR) from GSMA analysis of the 7 ADHD linkage scans. The thresholds of nominal (P¼ 0.05)
suggestive (P¼ 0.0083) and genome-wide significant linkage (P¼0.000417 after Bonferroni correction) are shown.
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Although the majority of the subjects included in this
study have white European ancestry, the potential influence of
genetic heterogeneity (namely population specific loci) on
the GSMA analysis should not be ignored [Zintzaras and
Ioannidis, 2005a; Lewis and Levinson, 2006]. For example
the Arcos-Burgos study used extended pedigrees from a Paisa
population isolate from Columbia and identified genome-wide
significant linkage on chromosome 4q13 which was confirmed
by further fine mapping [Arcos-Burgos et al., 2004].
In summary, this GSMA analysis of all seven published
ADHD linkage scans suggests that some chromosome regions
identified in the original studies might harbor ADHD genes. As
shown by the recent identification of CNTNAP2 as an autism
susceptibility gene, linkage evidence can play an important
role in gene discovery [Alarcon et al., 2008; Arking et al., 2008;
Stephan, 2008]. We conclude that chromosome regions such as
16q22–16q24 which show genome-wide significant linkage are
worthy of attention even in the era of genome-wide association
studies.
ACKNOWLEDGMENTS
The Asherson et al. study is supported by NIH (R01HD37694
and R01MH62873 to S.V.F.). The Ogdie et al. study is
supported by NIMH (MH058277 to S.L.S. and MH071852 to
S.F.N.), and a fellowship from the Academy of Finland
(Ekholm), The Bakker et al. study is supported by the
Mammalian Genotyping Service of the Marshfield Medical
Research Foundation, and by grants from the Makaria
Foundation, the UMC Utrecht’s Genvlag program, and the
Catharijne Foundation, J.M. and C.F. are supported by the
Deutsche Forschungsgemeinschaft (DFG ME 1923/5-1, ME
1923/5-3, GRK 1389/1); M.R., C.J., T.T.N., S.W., T.J.R., A.W.,
H.S., A.R., and K.P.L. are supported by the Deutsche
Forschungsgemeinschaft (DFG: KFO 125, SFB 581) and the
Bundesministerium fu¨r Bildung und Forschung (BMBF:
01GV0605), GSMA methodology development is supported by
MRC (G0400960 to C.M.L.).
REFERENCES
Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM,
Sebat J, Wigler M, Martin CL, Ledbetter DH, et al. 2008. Linkage,
association, and gene-expression analyses identify CNTNAP2 as an
autism-susceptibility gene. Am J Hum Genet 82:150–159.
Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD,
Palacio LG, Rapoport JL, Berg K, Bailey-Wilson JE, Muenke M. 2004.
Attention-deficit/hyperactivity disorder in a population isolate: Linkage
to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 75:998–
1014.
Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, Rea A,
Guy M, Lin S, Cook EH. et al. 2008. A common genetic variant in the
neurexin superfamily member CNTNAP2 increases familial risk of
autism. Am J Hum Genet 82:160–164.
Asherson P. 2004. Attention-deficit hyperactivity disorder in the post-
genomic era. Eur Child Adolesc Psychiatry 13 (Suppl 1):I50–I70.
Asherson P, Zhou K, Anney RJ, Franke B, Buitelaar J, Ebstein R, Gill M,
Altink M, Arnold R, Boer F, et al. 2008. A high-density SNP linkage scan
with 142 combined subtype ADHD sib pairs identifies linkage regions on
chromosomes 9 and 16. Mol Psychiatry 13:514–521.
Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL,
Monsuur AJ, van’t SR, Minderaa RB, Gunning WB, Pearson PL, et al.
2003. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/
hyperactivity disorder: Suggestive evidence for linkage on chromosomes
7p and 15q. Am J Hum Genet 72:1251–1260.
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA,
Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity
disorder. Biol Psychiatry 57:1313–1323.
Faraone SV, Doyle AE, Lasky-Su J, Sklar PB, D’Angelo E, Gonzalez-
Heydrich J, Kratochvil C, Mick E, Klein K, Rezac AJ, et al. 2007. Linkage
analysis of attention deficit hyperactivity disorder. Am J Med Genet B
Neuropsychiatr Genet (in press).
Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL,
Newbury DF, Crawford LR, Palmer CG, Woodward JA, et al. 2002. A
genomewide scan for loci involved in attention-deficit/hyperactivity
disorder. Am J Hum Genet 70:1183–1196.
Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M,
Freitag C, Seitz C, Palmason H, et al. 2007. Association and linkage of
allelic variants of the dopamine transporter gene in ADHD. Mol
Psychiatry 12:923–933.
Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder
M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, et al. 2006. A
genome-wide scan for attention-deficit/hyperactivity disorder in 155
German sib-pairs. Mol Psychiatry 11:196–205.
Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA,
Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G,
et al. 2002. A high-resolution recombination map of the human genome.
Nat Genet 31:241–247.
Lander E, Kruglyak L. 1995. Genetic dissection of complex traits: Guidelines
for interpreting and reporting linkage results. Nat Genet 11:241–
247.
Levinson DF, Levinson MD, Segurado R, Lewis CM. 2003. Genome scan
meta-analysis of schizophrenia and bipolar disorder, part I: Methods and
power analysis. Am J Hum Genet 73:17–33.
Lewis CM, Levinson DE. 2006. Testing for genetic heterogeneity in the
genome search meta-analysis method. Genet Epidemiol 30:348–
355.
Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I,
Williams NM, Schwab SG, Pulver AE, Faraone SV, et al. 2003. Genome
scan meta-analysis of schizophrenia and bipolar disorder, part II:
Schizophrenia. Am J Hum Genet 73:34–48.
Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C,
Cantor RM, McCracken JT, McGough JJ, Nelson SF, et al. 2003. A
genomewide scan for attention-deficit/hyperactivity disorder in an
extended sample: Suggestive linkage on 17p11. Am J Hum Genet 72:
1268–1279.
Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK, Cantor RM,
McCracken JT, McGough JJ, Smalley SL, et al. 2004. Attention deficit
hyperactivity disorder: Fine mapping supports linkage to 5p13, 6q12,
16p13, and 17p11. Am J Hum Genet 75:661–668.
Ogdie MN, Bakker SC, Fisher SE, Francks C, Yang MH, Cantor RM, Loo SK,
van der ME, Pearson P, Buitelaar J, et al. 2006. Pooled genome-wide
linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a
common risk locus at 5p13. Mol Psychiatry 11:5–8.
Fig. 2. Individual linkage scan results for chromosome 16q (bins
16.3–16.4) from 6 studies.
Attention Deficit Hyperactivity Disorder 1397
Pardi F, Levinson DF, Lewis CM. 2005. GSMA: Software implementation of
the genome search meta-analysis method. Bioinformatics 21:4430–4431.
Risch N, Merikangas K. 1996. The future of genetic studies of complex
human diseases. Science 273:1516–1517.
Romanos M, Freitag C, Jacob C, Craig DW, Dempfle A, Nguyen TT, Halperin
R, Walitza S, Renner TJ, Seitz C, et al. 2008. Genome-wide linkage
analysis of ADHD using high-density SNP arrays: Novel loci at 5q13.1
and 14q12. Mol Psychiatry 13:522–530.
Stephan DA. 2008. Unraveling autism. Am J Hum Genet 82:7–9.
Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T, Harano M,
Sekine Y, Inada T, Ozaki N, et al. 2008. Genome-wide association for
methamphetamine dependence: Convergent results from 2 samples.
Arch Gen Psychiatry 65:345–355.
Waldman ID, Gizer IR. 2006. The genetics of attention deficit hyperactivity
disorder. Clin Psychol Rev 26:396–432.
Wise LH, Lanchbury JS, Lewis CM. 1999. Meta-analysis of genome
searches. Ann Hum Genet 63:263–272.
Zintzaras E, Ioannidis JP. 2005a. Heterogeneity testing in meta-analysis of
genome searches. Genet Epidemiol 28:123–137.
Zintzaras E, Ioannidis JP. 2005b. HEGESMA: Genome search meta-
analysis and heterogeneity testing. Bioinformatics 21:3672–
3673.
1398 Zhou et al.
